Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
XOMA Royaltyxoma.com · Low evidenceXOMA Royalty is a biotech royalty aggregator that acquires the economic rights to future milestone and royalty payments associated with partnered pre-commercial clinical candidates. The company provides non-dilutive, non-recourse funding to biotech firms in exchange for these rights, managing a portfolio of over 120 assets.
Parse Score